Literature DB >> 24892801

Protein kinase C inhibitors for immune disorders.

Amnon Altman1, Kok-Fai Kong2.   

Abstract

Protein kinase C (PKC) proteins are a group of well-conserved, intracellular signaling enzymes expressed in all cells and tissues, including immune cells. Much of the molecular insight into PKC immunobiology has been gleaned from studies using PKC gene (Prkc) knockout mice and the analysis of different disease models in these animals. More-recent studies have revealed that PKCs also have crucial roles in the pathogenesis of human immune disorders. Therefore, strategies to modulate the functions of PKC enzymes could have a major impact on the treatment and therapies of autoimmune diseases and other immune disorders.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24892801      PMCID: PMC4138286          DOI: 10.1016/j.drudis.2014.05.008

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  42 in total

1.  PKCθ: a new target for selective immunosuppression.

Authors:  Amnon Altman; Kok-Fai Kong
Journal:  Expert Rev Clin Immunol       Date:  2012-03       Impact factor: 4.473

2.  Protein kinase C-theta mediates negative feedback on regulatory T cell function.

Authors:  Alexandra Zanin-Zhorov; Yi Ding; Sudha Kumari; Mukundan Attur; Keli L Hippen; Maryanne Brown; Bruce R Blazar; Steven B Abramson; Juan J Lafaille; Michael L Dustin
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

Review 3.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

4.  Protein kinase C-theta is required for efficient positive selection.

Authors:  Sharon Celeste Morley; K Scott Weber; Henry Kao; Paul M Allen
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta.

Authors:  Akimoto Miyamoto; Keiko Nakayama; Hiroyuki Imaki; Sachiko Hirose; Yi Jiang; Masaaki Abe; Tadasuke Tsukiyama; Hiroyasu Nagahama; Shigeo Ohno; Shigetsugu Hatakeyama; Keiichi I Nakayama
Journal:  Nature       Date:  2002-04-25       Impact factor: 49.962

6.  Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells.

Authors:  G Baier; D Telford; L Giampa; K M Coggeshall; G Baier-Bitterlich; N Isakov; A Altman
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

7.  Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.

Authors:  Alexandra Zhernakova; Eli A Stahl; Gosia Trynka; Soumya Raychaudhuri; Eleanora A Festen; Lude Franke; Harm-Jan Westra; Rudolf S N Fehrmann; Fina A S Kurreeman; Brian Thomson; Namrata Gupta; Jihane Romanos; Ross McManus; Anthony W Ryan; Graham Turner; Elisabeth Brouwer; Marcel D Posthumus; Elaine F Remmers; Francesca Tucci; Rene Toes; Elvira Grandone; Maria Cristina Mazzilli; Anna Rybak; Bozena Cukrowska; Marieke J H Coenen; Timothy R D J Radstake; Piet L C M van Riel; Yonghong Li; Paul I W de Bakker; Peter K Gregersen; Jane Worthington; Katherine A Siminovitch; Lars Klareskog; Tom W J Huizinga; Cisca Wijmenga; Robert M Plenge
Journal:  PLoS Genet       Date:  2011-02-24       Impact factor: 5.917

8.  Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection.

Authors:  A Castrillo; D J Pennington; F Otto; P J Parker; M J Owen; L Boscá
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

9.  Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.

Authors:  Jason D Cooper; Deborah J Smyth; Adam M Smiles; Vincent Plagnol; Neil M Walker; James E Allen; Kate Downes; Jeffrey C Barrett; Barry C Healy; Josyf C Mychaleckyj; James H Warram; John A Todd
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

10.  Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells.

Authors:  Christa Pfeifhofer; Kurt Kofler; Thomas Gruber; Nassim Ghaffari Tabrizi; Christina Lutz; Karl Maly; Michael Leitges; Gottfried Baier
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  10 in total

1.  Intracellular Delivery of Anti-pPKCθ (Thr538) via Protein Transduction Domain Mimics for Immunomodulation.

Authors:  E Ilker Ozay; Gabriela Gonzalez-Perez; Joe A Torres; Jyothi Vijayaraghavan; Rebecca Lawlor; Heather L Sherman; Daniel T Garrigan; Amy S Burnside; Barbara A Osborne; Gregory N Tew; Lisa M Minter
Journal:  Mol Ther       Date:  2016-09-16       Impact factor: 11.454

2.  The C1 domain of Vav3, a novel potential therapeutic target.

Authors:  Jessica S Kelsey; Tamás Géczy; Christopher J Kaler; Peter M Blumberg
Journal:  Cell Signal       Date:  2017-09-18       Impact factor: 4.315

Review 3.  Protein kinase C in the immune system: from signalling to chromatin regulation.

Authors:  Pek Siew Lim; Christopher Ray Sutton; Sudha Rao
Journal:  Immunology       Date:  2015-10-06       Impact factor: 7.397

4.  Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer.

Authors:  Tina Horbach; Claudia Götz; Thomas Kietzmann; Elitsa Y Dimova
Journal:  Front Pharmacol       Date:  2015-02-18       Impact factor: 5.810

5.  Bioinformatics analysis to screen for critical genes between survived and non‑survived patients with sepsis.

Authors:  Yanfeng Wu; Lei Zhang; Ying Zhang; Yong Zhen; Shouyue Liu
Journal:  Mol Med Rep       Date:  2018-08-21       Impact factor: 2.952

Review 6.  Aberrance of Zinc Metalloenzymes-Induced Human Diseases and Its Potential Mechanisms.

Authors:  Yunqi Cheng; Hongping Chen
Journal:  Nutrients       Date:  2021-12-13       Impact factor: 5.717

Review 7.  Targeting Protein Kinase C for Cancer Therapy.

Authors:  Sijia He; Qi Li; Qian Huang; Jin Cheng
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

8.  Pharmacophore modeling, docking and molecular dynamics simulation for identification of novel human protein kinase C beta (PKCβ) inhibitors.

Authors:  Sergiy A Starosyla; Galyna P Volynets; Mykola V Protopopov; Volodymyr G Bdzhola; Denis O Pashevin; Valentyna O Polishchuk; Taisiia O Kozak; Dmytro O Stroi; Victor E Dosenko; Sergiy M Yarmoluk
Journal:  Struct Chem       Date:  2022-10-11       Impact factor: 1.795

9.  Protein kinase C theta is required for efficient induction of IL-10-secreting T cells.

Authors:  Graham J Britton; Ruth E Mitchell; Bronwen R Burton; David C Wraith
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

10.  Mast Cell Activation and Microtubule Organization Are Modulated by Miltefosine Through Protein Kinase C Inhibition.

Authors:  Zuzana Rubíková; Vadym Sulimenko; Tomáš Paulenda; Pavel Dráber
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.